{"nct_id":"NCT03944772","title":"Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2019-06-25","start_date_type":"ACTUAL","primary_completion_date":"2025-05-06","primary_completion_date_type":"ESTIMATED","completion_date":"2025-05-06","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}